Visine Red Eye Hydrating Comfort Solution/ Drops
NDC Package 67751-198-01
Package Information
Visine Red Eye Hydrating Comfort (tetrahydrozoline hydrochloride and polyethylene glycol 400) solution/ dropses is adults and children 6 years of age and over: put 1 or 2 drops in the affected eye(s) up to 4 times a daychildren under 6 years of age: consult a doctorchildren under 2 years of age: do not use. This formulation utilizes a solution/ drops delivery system. Marketed by Navajo Manufacturing Company Inc., this product is identified by NDC 67751-198 and is authorized under FDA application 505G(a)(3).
Identification & Billing
- RxCUI: 996209 - polyethylene glycol 400 1 % / tetrahydrozoline HCl 0.05 % Ophthalmic Solution
- RxCUI: 996209 - polyethylene glycol 400 10 MG/ML / tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution
- RxCUI: 996209 - PEG 400 1 % / tetrahydrozoline hydrochloride 0.05 % Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 67751 - Navajo Manufacturing Company Inc.
- 67751-198 - Visine Red Eye Hydrating Comfort
- 67751-198-01 - 1 BOTTLE, DROPPER in 1 BLISTER PACK / 8 mL in 1 BOTTLE, DROPPER
- 67751-198 - Visine Red Eye Hydrating Comfort
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67751-198-01 identifies a specific commercial package of 1 bottle, dropper in 1 blister pack / 8 ml in 1 bottle, dropper of Visine Red Eye Hydrating Comfort Eye Drops, a human over the counter drug labeled by Navajo Manufacturing Company Inc.. This solution/ drops is formulated for ophthalmic use and contains polyethylene glycol 400; tetrahydrozoline hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Navajo Manufacturing Company Inc. on June 01, 2020. The current certification is valid through December 31, 2026.
How is this Navajo Manufacturing Company Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67751019801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.